A total of 610 (30%) patients had ACAs in addition to t(9;22)(q34;q11.2)/BCR-ABL. Of note, cases with chromosomal changes in Ph-negative cells were not considered as ACAs. Of 610 cases with ACAs, 183 ...
Hypocellular acute myeloid leukemia: Better or worse prognosis. Background: FLT3 (fms-related tyrosine kinase 3) with internal tandem duplication (ITD) is a known adverse prognostic factor in normal ...
Predictive factors associated with achievement of major cytogenetic response (MCyR) to omacetaxine mepesuccinate among patients with chronic phase chronic myeloid leukemia (CML-CP). Incidence and ...
—According to researchers in Germany, the presence of additional cytogenetic or molecular markers included in current risk stratification systems, rather than the presence or absence of a trisomy 8, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results